Body mass index and weight change in men with prostate cancer: Progression and mortality

Cancer Causes and Control

Volumn 25, Issue 8, 2014, Pages 933-943

  Bonn, Stephanie E ^a   Wiklund, Fredrik ^a   Sjölander, Arvid ^a   Szulkin, Robert ^a   Stattin, Pär ^b   Holmberg, Erik ^c   Grönberg, Henrik ^a   Bälter, Katarina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Body mass index; Disease progression; Epidemiology; Mortality; Prostatic neoplasms; Weight change

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNIC GROUP; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; SMOKING HABIT; SURVIVAL RATE; SWEDISH; WEIGHT CHANGE; DISEASE COURSE; LIFESTYLE; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; SWEDEN; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; BODY MASS INDEX; DISEASE PROGRESSION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; SWEDEN; WEIGHT GAIN; WEIGHT LOSS;

EID: 84904550035     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0393-3     Document Type: Article

References (41)

1. Bergman O, Hont G, Johansson E (ed) (2013) The National Board of Health and Welfare, Stockholm, Sweden. http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/19108/2013-6-5.pdf. Accessed 18 Oct 2013 (In Swedish: Cancer i siffror 2013)
2. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
3. Meyerhardt JA, Ma J, Courneya KS (2010) Energetics in colorectal and prostate cancer. J Clin Oncol 28(26):4066-4073
4. Stattin P, Holmberg E, Bratt O et al (2008) Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 180(6):2423-2429 (discussion 2429-2430)
5. Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174(3):1065-1070
6. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 68(4):899-917
7. World Health Organization (2012) World Health Statistics 2012. http://www.who.int/gho/publications/world-health-statistics/EN-WHS2012-Full.pdf. Accessed 18 Oct 2013
8. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121(7):1571-1578 (Pubitemid 47328718)
9. Rodriguez C, Freedland SJ, Deka A et al (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarker Prev 16(1):63-69 (Pubitemid 46174265)
10. Stocks T, Hergens MP, Englund A, Ye W, Stattin P (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127(7):1660-1668
11. Mistry T, Digby JE, Desai KM, Randeva HS (2007) Obesity and prostate cancer: a role for adipokines. Eur Urol 52(1):46-53 (Pubitemid 46803036)
12. Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV (2007) Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 109(8):1493-1498 (Pubitemid 46595683)
13. Palma D, Pickles T, Tyldesley S (2007) Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int 100(2):315-319 (Pubitemid 47036558)
14. Strom SS, Kamat AM, Gruschkus SK et al (2006) Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107(3):631-639 (Pubitemid 44107225)
15. Strom SS, Wang XM, Pettaway CA et al (2005) Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11(19):6889-6894 (Pubitemid 41428745)
16. Bassett WW, Cooperberg MR, Sadetsky N et al (2005) Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66(5):1060-1065 (Pubitemid 41587161)
17. Ly D, Reddy CA, Klein EA, Ciezki JP (2010) Association of body mass index with prostate cancer biochemical failure. J Urol 183(6):2193-2199
18. Cao Y, Ma J (2011) Body-mass index, prostate cancer-specific mortality and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 4(4):486-501
19. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR (2007) Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109(6):1192-1202 (Pubitemid 46435400)
20. Efstathiou JA, Bae K, Shipley WU et al (2007) Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31. Cancer 110(12):2691-2699 (Pubitemid 350250338)
21. Ma J, Li H, Giovannucci E et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039-1047
22. Haggstrom C, Stocks T, Ulmert D et al (2012) Prospective study on metabolic factors and risk of prostate cancer. Cancer 118(24):6199-6206
23. Bassett JK, Severi G, Baglietto L et al (2012) Weight change and prostate cancer incidence and mortality. Int J Cancer 131(7):1711-1719
24. Wright ME, Chang SC, Schatzkin A et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675-684 (Pubitemid 46233228)
25. Joshu CE, Mondul AM, Menke A et al (2011) Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 4(4):544-551
26. Whitley BM, Moreira DM, Thomas JA et al (2011) Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. Prostate Cancer Prostatic Dis 14(4):361-366
27. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27-33
28. Van Hemelrijck M, Wigertz A, Sandin F et al (2012) Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol 42(4):956-967
29. Szulkin R, Holmberg E, Stattin P et al (2012) Prostate cancer risk variants are not associated with disease progression. Prostate 72(1):30-39
30. Norman A, Bellocco R, Bergstrom A, Wolk A (2001) Validity and reproducibility of self-reported total physical activity - differences by relative weight. Int J Obes Relat Metab Disord 25(5):682-688 (Pubitemid 32417638)
31. Messerer M, Johansson SE, Wolk A (2004) The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr 134(7):1800-1805 (Pubitemid 38886572)
32. Cox DR (1972) Regression models and life-tables. J R Stat Soc B 34(2):187
33. Discacciati A, Orsini N, Wolk A (2012) Body mass index and incidence of localized and advanced prostate cancer - a dose-response meta-analysis of prospective studies. Ann Oncol 23(7):1665-1671
34. Tomaszewski JJ, Chen YF, Bertolet M et al (2013) Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Urology 81(5):992-996
35. Banez LL, Hamilton RJ, Partin AW et al (2007) Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 298(19):2275-2280 (Pubitemid 350146217)
36. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301-316
37. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocr Metab 17(8):328-336 (Pubitemid 44397568)
38. Schnoeller T, Jentzmik F, Rinnab L et al (2013) Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J Urol 31(2):253-259
39. Kovalchik S (2009) Validity of adult lifetime self-reported body weight. Public Health Nutr 12(8):1072-1077
40. Prentice AM, Jebb SA (2001) Beyond body mass index. Obes Rev 2(3):141-147 (Pubitemid 33755907)
41. Mucksavage P, Mitchell C, Kutikov A et al (2012) Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. Urol Oncol 30(5):590-595